Molecular classification and drug response prediction in cancer

Area of Science:

• Oncology
• Genomics
• Pharmacology

Background:

• Molecular profiling of cancers offers potential for novel gene markers to guide targeted therapy.
• Publicly available gene expression data and drug response data from cancer cell lines can reveal oncogenic pathway dysregulation and gene-drug correlations.

Purpose of the Study:

• To review recent studies on using tumor molecular profiles for predicting drug response.
• To highlight the potential of publicly available data for identifying novel therapeutic biomarkers.

Main Methods:

• Examination of studies utilizing gene expression profiling of tumors and cell lines.
• Analysis of publicly accessible datasets linking molecular profiles to drug responses.
• Review of research on profiling tumors from patients receiving neoadjuvant or adjuvant therapy.

Main Results:

• Molecular profiling can identify gene markers predictive of therapeutic response.
• Public data repositories provide a rich resource for discovering gene-drug correlations.
• Re-analysis of existing data can yield new biomarker candidates.

Conclusions:

• Molecular profiling holds significant promise for tailoring cancer therapies to individual patients.
• The availability of public data facilitates the discovery and validation of predictive biomarkers.
• Further research and clinical testing are needed to translate these findings into routine practice.